187 related articles for article (PubMed ID: 8377721)
1. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort].
Rotenberger J; Köbberling J
Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721
[No Abstract] [Full Text] [Related]
2. Deflazacort in pediatric rheumatic diseases needs a frequent follow-up of bone densitometry.
Falcini F; Trapani S; Ermini M; Bartolozzi G
Pediatrics; 1995 Feb; 95(2):318. PubMed ID: 7838659
[No Abstract] [Full Text] [Related]
3. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
LoCascio V; Ballanti P; Milani S; Bertoldo F; LoCascio C; Zanolin EM; Bonucci E
Calcif Tissue Int; 1998 Mar; 62(3):199-204. PubMed ID: 9501951
[TBL] [Abstract][Full Text] [Related]
4. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M
Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
[TBL] [Abstract][Full Text] [Related]
5. Problems in evaluating dose equivalences of glucocorticoids.
Köbberling J; Rotenberger J
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):434-6. PubMed ID: 1490770
[No Abstract] [Full Text] [Related]
6. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
[TBL] [Abstract][Full Text] [Related]
7. Steroid-induced osteoporosis.
Reid IR
Osteoporos Int; 1997; 7 Suppl 3():S213-6. PubMed ID: 9536335
[No Abstract] [Full Text] [Related]
8. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary consensus statement on glucocorticoid-induced osteoporosis].
Scharla SH; Buttgereit F; Dreher R; Felsenberg D; Franck H; Hein G; Lemmel EM; Rau R; Sieper J; Braun J
Z Rheumatol; 2001 Apr; 60(2):96-9. PubMed ID: 11383055
[No Abstract] [Full Text] [Related]
10. Deflazacort in giant cell arteritis.
Devogelaer JP; Gennari C
J Rheumatol; 2002 Oct; 29(10):2244-5. PubMed ID: 12375347
[No Abstract] [Full Text] [Related]
11. [Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis].
Nakayama H
Clin Calcium; 2006 Jul; 16(7):1201-7. PubMed ID: 16816482
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
van Staa TP; Leufkens HG; Cooper C
Osteoporos Int; 2002 Oct; 13(10):777-87. PubMed ID: 12378366
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid-induced osteoporosis in patients with uveitis.
Jones NP; Anderton LC; Cheong FM; Whallett A; Stanford MR; Murray PI; Lesnik-Oberstein S; Pavesio C
Eye (Lond); 2002 Sep; 16(5):587-93. PubMed ID: 12194074
[TBL] [Abstract][Full Text] [Related]
14. An overview of the adverse reactions to adrenal corticosteroids.
Frauman AG
Adverse Drug React Toxicol Rev; 1996 Nov; 15(4):203-6. PubMed ID: 9113247
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis and therapy of steroid-induced osteoporosis].
Braun J; Buttgereit F; Felsenberg D; Sieper J
Z Rheumatol; 2001 Apr; 60(2):100-3. PubMed ID: 11383042
[No Abstract] [Full Text] [Related]
16. Therapy and prophylaxis of corticosteroid induced osteoporosis.
Sambrook PN
Z Rheumatol; 2001 Apr; 60(2):120-2. PubMed ID: 11383049
[No Abstract] [Full Text] [Related]
17. An update on glucocorticoid-induced osteoporosis.
Woolf AD
Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
[TBL] [Abstract][Full Text] [Related]
18. Effects of prednisone and deflazacort on vertebral bone mass.
Gennari C; Imbimbo B
Calcif Tissue Int; 1985 Dec; 37(6):592-3. PubMed ID: 3937579
[TBL] [Abstract][Full Text] [Related]
19. Adrenal suppression and osteoporosis after treatment of nasal polyposis.
Bonfils P; Halimi P; Malinvaud D
Acta Otolaryngol; 2006 Dec; 126(11):1195-200. PubMed ID: 17050313
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
